주식/증권
📈 긍정적
Elite Pharmaceuticals Stock Slips Despite Record Fiscal 2026 Earnings
요약
ELTP delivers record fiscal 2026 results, with stronger profits, improved cash and pipeline progress supporting its expanding generics platform.